OPKO Health, Inc.

NASDAQ:OPK

Biotechnology

Healthcare
$1.69 +0.52%

+$0.01 today

Market cap
$1.25B
Beta
1.49
P/E (TTM)
-5.1
EPS (TTM)
-$0.28
52W Low $0.98High $1.60

Volume 3.06M

Average 2.59M

OPK Deferred Revenue (Non-current)

Payments received for goods or services the company will deliver after more than one year.

OPKO Health, Inc.NASDAQ: OPK

Deferred Revenue (Non-current) · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue (non-current) remains negative

Q1 FY2026 deferred revenue (non-current) was $0, compared with $0 a year earlier.

Context

  • Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Deferred revenue (non-current) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
Year agoMar 2025
$0— since
Deferred Revenue (Non-current) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue (Non-current) history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Deferred Revenue (Non-current) vs competitors

How OPK compares with its peers on the latest reported figures

  • OPK's Mar 2026 deferred revenue (non-current) of $0 is the 3rd highest of the 11 companies compared; the peer median is $0.
  • Deferred revenue (non-current) amounts to 0.0% of total assets for OPK, versus a peer median of 0.0%.
OPK Competitors Peer median
Deferred Revenue (Non-current) for OPK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NTRANatera, Inc.Jun 2026$16.07M -31.0%-5.2%0.6%
GHGuardant Health, Inc.Sep 2026$7M ——0.4%
OPKOPKO Health, Inc.Mar 2026$0 ——0.0%
BLLNBillionToOne, Inc.Jun 2026$0 ——0.0%
NEONeoGenomics, Inc.Jun 2026$0 -100.0%+172.9%0.0%
PSNLPersonalis, Inc.Mar 2026$0 ——0.0%
CSTLCastle Biosciences, Inc.Mar 2026$0 ——0.0%
FLGTFulgent Genetics, Inc.Mar 2026$0 ——0.0%
MYGNMyriad Genetics, Inc.Mar 2026$0 ——0.0%
XGNExagen Inc.Mar 2026$0 ——0.0%
MDXHMDxHealth S.A.Jun 2026$0 ——0.0%
Peer median (excluding OPK) $0-65.5%+83.9%0.0%

Competitors are the stored peer set for OPK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents134.71M153.19M95.88M431.94M369.07M
Short-term Investments00000
Net Receivables265.59M148.61M130.2M152.05M126.12M
Inventory86.5M74.06M65.7M56.8M65.82M
Other Current Assets321.19M6.25M7.67M10.71M8.17M
Total Current Assets823.01M394.53M309.48M662.09M581.88M
Property, Plant & Equipment (Net)123.96M121.6M143.52M124.14M120.86M
Goodwill520.6M595.85M598.26M529.25M484.29M
Intangible Assets911.88M1.02B935.28M811.61M516.28M
Long-term Investments10.71M28.05M16.08M54.58M14.17M
Tax Assets00000
Other Non-current Assets9.55M8.71M9.08M18.54M214.47M
Total Non-current Assets1.58B1.77B1.7B1.54B1.35B
Total Assets2.4B2.17B2.01B2.2B1.93B
Account Payables82.04M66.99M69.68M47.07M41.1M
Short-term Debt14.69M36.59M27.29M15.02M22.86M
Tax Payables05.35M1.38M22.28M0
Deferred Revenue258K0000
Other Current Liabilities74.1M40.24M56.92M41.09M82.72M
Total Current Liabilities330.01M213.48M200.05M193.1M146.68M
Long-term Debt190.16M219.47M222.03M422.18M370.53M
Deferred Tax Liabilities148.49M126.43M126.77M140.8M126.24M
Deferred Revenue (Non-current)208K138K7K6K0
Other Non-current Liabilities9.71M11.05M12.2M25.77M(19.67M)
Total Non-current Liabilities384.58M392.13M422.43M641.67M517.31M
Total Liabilities714.59M605.61M622.48M834.76M663.99M
Common Stock6.9M7.81M7.82M7.02M7.9M
Retained Earnings(1.51B)(1.82B)(2.01B)(2.07B)(2.29B)
Accumulated OCI(30.5M)(43.32M)(38.03M)(56.13M)(21.02M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.69B1.56B1.39B1.37B1.27B
Total Debt254.76M305.55M326.56M504.44M433.6M
Net Debt120.05M152.36M230.68M72.51M64.52M

OPKO Health, Inc.

NASDAQ:OPK

Intrinsic Alpha fair value

Locked

Current Price

$1.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.